HDFC Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
HDFC Pharma and Healthcare Fund is a Thematic fund and Mirae Asset Nifty 500 Healthcare ETF is an ETF fund. HDFC Pharma and Healthcare Fund charges 1.05% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%. Their portfolios overlap 61.5%: they hold 25 of the same securities.
HDFC Pharma and Healthcare Fund
Thematic
- Expense ratio
- 1.05%
- NAV
- ₹21.95
Mirae Asset Nifty 500 Healthcare ETF
ETF
- Expense ratio
- 0.35%
- NAV
- ₹21.44
Which is better, HDFC Pharma and Healthcare or Mirae Asset Nifty 500 Healthcare ETF? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Mirae Asset Nifty 500 Healthcare ETF costs less: 0.35% a year against 1.05%.
- Mirae Asset Nifty 500 Healthcare ETF fell less in its worst fall since 11-02-2026: −9.6% against −9.8%.
- HDFC Pharma and Healthcare is the larger fund: ₹3,501 Cr against ₹15 Cr.
- Their portfolios overlap 61.5%: 25 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | HDFC Pharma and Healthcare Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Fund house | HDFC Mutual Fund | Mirae Asset Mutual Fund |
| Category | Thematic | ETF |
| AUM | ₹3,501 Cr (30-09-2026) | ₹15 Cr (30-09-2026) |
| NAV | ₹21.95 (Direct) | ₹21.44 |
| Expense ratio (Direct) | 1.05% | Not available |
| Expense ratio (Regular) | 2.13% | Not available |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | Nifty500 Healthcare TRI |
| Launch date | 04-10-2023 | Not available |
| Minimum investment | ₹100 | On exchange in multiple of 1 unit. With AMC: In multiples of 5,000 units |
| Lock in | None | None |
| Fund managers | Nikhil Mathur, Gopal Agrawal, Bhagyesh Kagalkar | Ekta Gala, amp, Ritesh Patel |
| Exit load | In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched out after 30 days from the date of allotment. | NIL |
HDFC Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund (Direct) | +0.04% | +0.83% | +16.68% | +23.12% | +30.53% | -- | -- |
| Mirae Asset Nifty 500 Healthcare ETF | +1.43% | −0.66% | +12.95% | -- | -- | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | -- | -- |
Category average: the average of the 235 Thematic funds, same plan type.
HDFC Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Year-wise Returns
| Year | HDFC Pharma and HealthcareHDFC Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETFMirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| 2026to date | +23.99% | -- |
| 2025 | +2.42% | -- |
| 2024 | +52.22% | -- |
HDFC Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of HDFC Pharma and Healthcare Fund
HDFC Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | HDFC Pharma and Healthcare Fund (Direct) | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Return (CAGR) | +29.32% | +23.46% |
| Standard deviation | 13.98% | 14.16% |
| Sharpe ratio | 1.66 | 1.29 |
| Sortino ratio | 2.38 | 1.90 |
| Maximum drawdown | −14.9% (28-02-2025) | −9.6% (23-10-2026) |
| Beta | 0.95 | 1.00 |
| Alpha | +8.51% | −0.22% |
From daily NAVs, 04-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
HDFC Pharma and Healthcare Fund (Direct)
Mirae Asset Nifty 500 Healthcare ETF
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund (Direct) | −9.8% | 21-09-2026 | 23-10-2026 | Not yet | -- | −4.1% |
| Mirae Asset Nifty 500 Healthcare ETF | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.0% |
| BSE Healthcare TRI | −9.9% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.8% |
From daily values since 11-02-2026, the first day every fund has.
HDFC Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Portfolio Overlap
From each fund's latest monthly portfolio: HDFC Pharma and Healthcare Fund, September 2026; Mirae Asset Nifty 500 Healthcare ETF, September 2026
Holdings in common
- Overlap
- 61.5%
- Held by both
- 25
- Only in HDFC Pharma and Healthcare
- 13
- Only in Mirae Asset Nifty 500 Healthcare ETF
- 19
| Security | % of HDFC Pharma and Healthcare | % of Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Divis Laboratories Ltd. | 9.39% | 8.76% |
| Sun Pharmaceutical Industries Ltd. | 8.28% | 10.13% |
| Cipla Ltd. | 4.15% | 5.62% |
| Apollo Hospitals Enterprise Ltd. | 3.69% | 6.24% |
| Torrent Pharmaceuticals Ltd. | 3.65% | 5.24% |
| Max Healthcare Institute Limited | 3.61% | 5.13% |
| Lupin Ltd. | 3.55% | 3.66% |
| Dr Reddys Laboratories Ltd. | 3.19% | 5.58% |
| Alkem Laboratories Ltd. | 4.64% | 2.31% |
| Glenmark Pharmaceuticals Ltd. | 2.09% | 2.61% |
| Ipca Laboratories Ltd. | 2.98% | 1.98% |
| Zydus Lifesciences Limited | 1.82% | 2.14% |
| Gland Pharma Ltd. | 1.78% | 1.71% |
| Sai Life Sciences Limited | 1.58% | 1.56% |
| Krishna Institute Of Medical Sciences Limited | 2.10% | 1.48% |
| Biocon Ltd. | 1.47% | 1.91% |
| Aster DM Quality Care Limited | 3.56% | 1.38% |
| Neuland Laboratories Limited | 3.24% | 1.36% |
| Wockhardt Ltd. | 1.71% | 1.30% |
| Acutaas Chemicals Limited | 3.18% | 1.26% |
| Global Health Limited | 2.72% | 0.90% |
| Anthem Biosciences Limited | 3.17% | 0.69% |
| Vijaya Diagnostic Centre Limited | 2.00% | 0.52% |
| Rubicon Research Limited | 2.52% | 0.43% |
| Cohance Lifesciences Limited | 0.32% | 0.54% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 61.5% means 61.5% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in HDFC Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Shilpa Medicare Ltd | 3.23% |
| Molbio Diagnostics Limited | 2.01% |
| Jupiter Life Line Hospitals Limited | 1.68% |
| Metropolis Healthcare Ltd. | 1.67% |
| SYMBIOTEC PHARMALAB LIMITED | 1.36% |
Largest holdings only in Mirae Asset Nifty 500 Healthcare ETF
| Security | % of fund |
|---|---|
| Laurus Labs Ltd. | 5.72% |
| Aurobindo Pharma Ltd. | 3.43% |
| Fortis Healthcare Ltd. | 2.98% |
| Mankind Pharma Ltd. | 2.10% |
| Ajanta Pharma Ltd. | 1.22% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | HDFC Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Equity | 96.8% | 100.0% |
| Debt | 0.0% | 0.0% |
| Cash and others | 3.2% | 0.0% |
Market cap of stocks
| Market cap | HDFC Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Large Cap | 29.2% | 36.0% |
| Mid Cap | 30.1% | 45.6% |
| Small Cap | 32.5% | 18.3% |
| Not on AMFI's list | 5.0% | 0.0% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | HDFC Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Pharmaceuticals & Biotechnology | 71.3% | 77.8% |
| Healthcare Services | 22.1% | 21.7% |
| Healthcare Equipment & Supplies | 2.4% | 0.5% |
| Retailing | 1.0% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
HDFC Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | HDFC Pharma and Healthcare Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Total expense ratio (Direct) | 1.05% | Not available |
| Base expense ratio (Direct) | 0.71% | 0.00% |
| Total expense ratio (Regular) | 2.13% | Not available |
| Base expense ratio (Regular) | 1.65% | 0.16% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
HDFC Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF: Frequently Asked Questions
What is the difference between HDFC Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
HDFC Pharma and Healthcare Fund is a Thematic fund, Mirae Asset Nifty 500 Healthcare ETF is an ETF fund, run by HDFC Mutual Fund and Mirae Asset Mutual Fund. Their portfolios overlap 61.5%. HDFC Pharma and Healthcare Fund charges 1.05% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%.
Which has the lower expense ratio, HDFC Pharma and Healthcare Fund or Mirae Asset Nifty 500 Healthcare ETF?
Mirae Asset Nifty 500 Healthcare ETF charges less: 0.35% a year against 1.05%. These are the total expense ratios reported to AMFI.
How much do HDFC Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF overlap?
61.5%. They hold 25 of the same securities, the largest shared ones being DIVISLAB, SUNPHARMA, CIPLA. From each fund's latest monthly portfolio.
Which is riskier, HDFC Pharma and Healthcare Fund or Mirae Asset Nifty 500 Healthcare ETF?
On SEBI's riskometer, HDFC Pharma and Healthcare Fund is rated Very High and Mirae Asset Nifty 500 Healthcare ETF Very High. Over their common history, the standard deviation of daily returns was 13.98% and 14.16% a year.
Can I invest in both HDFC Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
Yes. 61.5% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages HDFC Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
HDFC Pharma and Healthcare Fund: Nikhil Mathur, Gopal Agrawal, Bhagyesh Kagalkar. Mirae Asset Nifty 500 Healthcare ETF: Ekta Gala, amp, Ritesh Patel.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.